Your shopping cart is empty

Subscriber login

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

Check out our free and informative ezines and sign up now

Home > Newsletters > Drug GMP Report > U.S. Marshals Seize Unapproved Drug From Crescendo Therapeutics

Drug GMP Report

June 2012

U.S. Marshals Seize Unapproved Drug From Crescendo Therapeutics

After a warning letter and two failed inspections, the FDA called in the big guns, requesting that U.S. marshals seize an unapproved, misbranded scar removal drug marketed by Crescendo Therapeutics.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives
Sample PDF

Baxter Warned About Mold, GMP Deviations at Two Plants Drugmakers Must Now State Reasons for Withdrawing Drugs in EU FDA Warns Indian Drug, API Maker for Deleting and Backdating Records Baxter Warned Over Contamination, GMP Deviations at Two Plants

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.